Clinical Trials in Ohio

Showing 12761-12780 of 17,983 trials

Weightbearing Assessment of Tarsal Instability

NCT01868789

The purpose of this study is to compare the average joint motion and joint axis orientation of the hindfoot bones between patients diagnosed with adult-acquired flatfoot disorder (AAFD) and a control group of patients without foot deformity, using weight-bearing CT technology.

Adult-acquired Flatfoot Disorder (AAFD)

Orthopedic Foot and Ankle Center, Ohio23 participantsStarted May 2013

Westerville, Ohio, United States

COMPLETEDPhase 232 miles

Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial

NCT02784392

The purpose of this study is to evaluate the effect Ulimorelin in patients with enteral feeding intolerance.

Enteral Feeding Intolerance (EFI)

Lyric Pharmaceuticals120 participantsStarted Oct 2016

New Orleans, Louisiana, United States • Columbus, Ohio, United States • Amsterdam, Netherlands +2 more locations

COMPLETEDPhase 232 miles

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

NCT00441090

The purpose of this study is to determine the efficacy, safety and tolerability, of AKR-501 (avatrombopag) tablets, as compared to placebo, in the treatment of participants with chronic Idiopathic Thrombocytopenic Purpura (ITP).

Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic

Eisai Inc.64 participantsStarted Feb 2007

Anaheim, California, United States • Bakersfield, California, United States • Concord, California, United States +22 more locations

Weightbearing Assessment of Tarsal Instability

Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Find Trials by Condition in Ohio

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

A Pilot Study Investigating the Clinical Use of Tissue Engineered Vascular Grafts in Congenital Heart Surgery

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?

Third International Study on Mechanical Ventilation

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Study of Carfilzomib for Multiple Myeloma Patients Who Are Relapsed/Refractory to Bortezomib-containing Treatments

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

The Captivator EMR Registry

Investigating the Effect of Vortioxetine in Adult ADHD Patients

Phase I Dose Escalation and Expansion of Oral BAY 1143269 in Combination With Intravenous Docetaxel